MOSCOW: Russia’s President Vladimir Putin told G20 leaders on Saturday that Russia was ready to provide its Sputnik V coronavirus vaccine to other countries who need it.
Russia is also preparing its second and third vaccine, Putin said, adding that creation of vaccine portfolio was “our common goal”.
Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.
Earlier this month, the country’s sovereign wealth fund said that the vaccine is 92% effective at protecting people from COVID-19 according to interim trial results.
The interim results were based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine, the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, said.
The so-called Phase III trial of the shot developed by the Gamaleya Institute is taking place in 29 clinics across Moscow and will involve 40,000 volunteers in total, with a quarter receiving a placebo shot.
The chances of contracting COVID-19 were 92% lower among people vaccinated with Sputnik V than those who received the placebo, the RDIF said.
That’s well above the 50% effectiveness threshold for COVID-19 vaccines set by the U.S. Food and Drug Administration.
Comments are closed.